Seek attention if you experience complete absence of bowel movements for more than a week, severe abdominal pain, vomiting, blood in stool, or signs of intestinal obstruction such as inability to pass gas combined with progressive abdominal distension
Fiber considerations for tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist with a slightly different side effect profile than pure GLP-1 agonists
This direct cytotoxicity may also cause alteration in the tertiary structure of proteins in connective tissue and hence affect the vascular wall structure (Lubec et al, 1996a
Pharmaceutical Research, 16 , 1412-1416
The reduction in ROS production, as a result of NRF2 activity, contributes to the destabilization of HIF1, furthering the anti-inflammatory activity of itaconate